Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship

MB Lustberg, NM Kuderer, A Desai… - Nature Reviews …, 2023 - nature.com
Despite the importance of chemotherapy-associated adverse events in oncology practice
and the broad range of interventions available to mitigate them, limited systematic efforts …

Management of perimenopausal and menopausal symptoms

ER Duralde, TH Sobel, JAE Manson - bmj, 2023 - bmj.com
Most women worldwide experience menopausal symptoms during the menopause transition
or postmenopause. Vasomotor symptoms are most pronounced during the first four to seven …

Vaginal estrogen therapy use and survival in females with breast cancer

L McVicker, AM Labeit, CAC Coupland, B Hicks… - JAMA …, 2024 - jamanetwork.com
Importance Genitourinary syndrome of menopause can be treated with vaginal estrogen
therapy. However, there are concerns about the safety of vaginal estrogen therapy in …

Genitourinary syndrome of menopause

S Cox, R Nasseri, RS Rubin… - Medical …, 2023 - medical.theclinics.com
Urogenital health is essential to maintaining the quality of life after menopause.
Genitourinary syndrome of menopause (GSM), first recognized in 2014, is characterized by …

Advances in the management of menopausal symptoms, fertility preservation, and bone health for women with breast cancer on endocrine therapy

M Lambertini, L Arecco, TL Woodard… - American Society of …, 2023 - ascopubs.org
In patients with hormone receptor–positive early-stage breast cancer, adjuvant endocrine
treatment administered for up to 5-10 years after diagnosis significantly reduces the risk of …

[HTML][HTML] Hormone replacement therapy

G Harper-Harrison, K Carlson… - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Hormone Replacement Therapy - StatPearls - NCBI Bookshelf US flag An official website of
the United States government Here's how you know NIH NLM Logo Access keys NCBI …

Managing menopause after cancer

M Hickey, P Basu, J Sassarini, ME Stegmann… - The Lancet, 2024 - thelancet.com
Globally, 9 million women are diagnosed with cancer each year. Breast cancer is the most
commonly diagnosed cancer worldwide, followed by colorectal cancer in high-income …

Therapeutic choices for genitourinary syndrome of menopause (GSM) in breast cancer survivors: a systematic review and update

L Merlino, G D'Ovidio, V Matys, MG Piccioni… - Pharmaceuticals, 2023 - mdpi.com
(1) Background: Genitourinary syndrome of menopause (GSM) is a medical condition that
can affect breast cancer survivors (BCS). This is a complication that often can occur as a …

Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts' perspective

S Rozenberg, N Panay, M Gambacciani… - Expert Review of …, 2023 - Taylor & Francis
Introduction Around 80% of women suffer menopause-related symptoms that affect their
daily activities and quality of life. Menopausal hormone therapy (MHT) has proven to be …

Endocrine therapy for surgeons: practical pearls for managing menopausal, bone loss and sexual adverse effects

K Rojas, LM Spring, L O'Riordan, A Weiss - Annals of surgical oncology, 2023 - Springer
Breast cancer patients are living longer than ever before and as such the population of
breast cancer survivors continues to grow. Approximately 80% of breast cancers are …